Keyphrases
Australian Population
100%
Women with Breast Cancer
100%
Comorbidity
100%
Population-based Cohort Study
100%
Aromatase Inhibitors
100%
Cardiovascular Disease
33%
Pharmaceutical Benefits Scheme
33%
Inflammation
33%
Breast Cancer
33%
Cancer Control
33%
Osteoporosis
33%
Non-cancer
33%
Endocrine Therapy
33%
High Risk
16%
Australian Women
16%
Diabetes
16%
Claims Data
16%
Comorbid Conditions
16%
Retrospective Cohort Study
16%
High Incidence
16%
Cox Regression Model
16%
Low Incidence
16%
Hormone Receptor-positive Breast Cancer
16%
V-model
16%
Antineoplastic Agents
16%
Development Mechanism
16%
Management Mechanism
16%
Long-term Cancer Survival
16%
Dispensing Claims
16%
Comorbidity Patterns
16%
Comorbidity Profile
16%
Medicine and Dentistry
Cohort Analysis
100%
Breast Cancer
100%
Comorbidity
100%
Comorbidity in Women
100%
Aromatase Inhibitor
100%
Tamoxifen
100%
Malignant Neoplasm
33%
Cancer Control
33%
Osteoporosis
33%
Cardiovascular Condition
33%
Hyperlipidemia
33%
Hormone Therapy
33%
Diabetes
16%
Retrospective Cohort Study
16%
Proportional Hazards Model
16%
Cancer Survival
16%
Anticarcinogen
16%
Pharmacology, Toxicology and Pharmaceutical Science
Comorbidity
100%
Cohort Study
100%
Breast Cancer
100%
Tamoxifen
100%
Aromatase Inhibitor
100%
Malignant Neoplasm
57%
Inflammation
28%
Hyperlipidemia
28%
Endocrine Therapy
28%
Cancer Survival
14%
Anticarcinogen
14%